» Articles » PMID: 35975974

The Immune Cell Infiltrate in the Tumour Microenvironment of Phaeochromocytomas and Paragangliomas

Overview
Specialties Endocrinology
Oncology
Date 2022 Aug 17
PMID 35975974
Authors
Affiliations
Soon will be listed here.
Abstract

Emerging evidence suggests the composition of the tumour microenvironment (TME) correlates with clinical outcome and that each tumour type has a unique TME including a variable population of inflammatory cells. We performed immunohistochemistry on 65 phaeochromocytoma and paraganglioma (PPGL) tumour samples with 20 normal adrenal medulla samples for comparison. The immune cells assessed were macrophages, lymphocytes and neutrophils, and we compared the proportion of infiltration of these immune cells with clinical and histopathological factors. There was a higher proportion of immune cells in tumour tissue compared to non-neoplastic adrenal medulla tissue, with a predominance of macrophages. There was a higher proportion of M2:M1 macrophages and T-helper lymphocytes in aggressive tumours compared to indolent ones. For SDHB-associated tumours, there was a higher proportion of M2 macrophage infiltration, with higher M2:M1 in aggressive SDHB PPGLs compared to indolent tumours. These data demonstrate that immune cells do infiltrate the TME of PPGLs, confirming that PPGLs are immunologically active tumours. Differences in the TME of PPGLs were observed between aggressive and indolent tumours. These differences could potentially be exploited as an aid in predicting tumour behaviour.

Citing Articles

Prognosis and tumor microenvironment in pseudohypoxic pheochromocytoma/paraganglioma.

Ohmoto A, Shigematsu Y, Saito R, Dobashi A, Fujiwara Y, Togashi Y Virchows Arch. 2024; .

PMID: 39694932 DOI: 10.1007/s00428-024-04009-x.


Functional analysis of fibroblasts and macrophages in head and neck paragangliomas.

Baruah P, Marshall J, Nefla M, Pucino V, Adams H, Turner J Front Endocrinol (Lausanne). 2024; 15:1397839.

PMID: 39619326 PMC: 11604431. DOI: 10.3389/fendo.2024.1397839.


Proteomic characterization of head and neck paraganglioma and its molecular classification.

Wang X, Sun J, Feng G, Tian X, Zhao Y, Gao Z Front Mol Neurosci. 2024; 17:1391568.

PMID: 39234408 PMC: 11371750. DOI: 10.3389/fnmol.2024.1391568.


[Advance in HIF expression and immune microenvironment in pseudohypoxic HNPGL].

Zhang B, Lou Z, Wang J, Hu Y, Chen Z Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024; 38(9):823-829.

PMID: 39193740 PMC: 11839587. DOI: 10.13201/j.issn.2096-7993.2024.09.009.


[Endothelial cells and fibroblasts mediate the microenvironmental regulatory network of carotid body paraganglioma].

Zhang B, Wang S, Hu Y, Luo C, Li S, Lou Z Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024; 38(9):788-796.

PMID: 39193734 PMC: 11839575. DOI: 10.13201/j.issn.2096-7993.2024.09.003.


References
1.
Lan C, Huang X, Lin S, Huang H, Cai Q, Wan T . Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol Cancer Res Treat. 2013; 12(3):259-67. DOI: 10.7785/tcrt.2012.500312. View

2.
Jimenez C, Subbiah V, Stephen B, Ma J, Milton D, Xu M . Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas. Cancers (Basel). 2020; 12(8). PMC: 7465458. DOI: 10.3390/cancers12082307. View

3.
Fang W, Ye L, Shen L, Cai J, Huang F, Wei Q . Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8. Carcinogenesis. 2014; 35(8):1780-7. DOI: 10.1093/carcin/bgu060. View

4.
Guadagno E, Russo D, Pignatiello S, Del Basso De Caro M . Inflammation in the neoplasms of the adrenal gland: Is there a prognostic role? An immunohistochemical study. Pathol Res Pract. 2020; 216(9):153070. DOI: 10.1016/j.prp.2020.153070. View

5.
Thorsson V, Gibbs D, Brown S, Wolf D, Bortone D, Yang T . The Immune Landscape of Cancer. Immunity. 2018; 48(4):812-830.e14. PMC: 5982584. DOI: 10.1016/j.immuni.2018.03.023. View